A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

Clinical trial NCT00720408 · COMPLETED

Trial details

NCT number: NCT00720408
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Liver Transplantation Transplantation Immunology Host vs Graft Reaction

Start date: 2007-12-01
Primary completion: 2009-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.